ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
NOVOZYMES A/S: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
-192.000M{"amount": -192000000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Entity
- NOVOZYMES A/S
- Metric
- cashflow_financing
- Period
- 2022-01-01 – 2022-03-31
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900T6WNZXD2R3JW38:2023-03-31Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-24T00:43:50.693219+02:00
Raw response SHA-256
0b47c812a3f707c17dc3727c84b7c0ea…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.